0–3 months
Short-horizon analog inside a six-month survey: the air-freight chart printed a 10 percent increase. Member comments cite delays of 5-7 days. Neither figure is a year-over-year price index. No Australian device PPI was opened.
A 2027 U.S.–China conflict with Australia aligned to the U.S. China trade stops immediately, Taiwan exports are slowed/limited, and China launches large‑scale cyber disruption in waves. Planning scenario, not a forecast. No end date is set.
Medical devices — Australia (Investor-Grade, Downstream Focus)
What happens
Australia is an importer and a clinical user, with a narrow manufacturing exception. WITS trade value for HS 9018 imports in 2024 is in thousand U.S. dollars. The world total was $2,945,335.84 thousand. This basket is instruments and appliances. It is not the wider U.S. HS 9018-9022 book, and the two are not averaged.
The United States supplied $1,056,129.49 thousand. Dividing those two printed values and rounding to one decimal, the calculated United States share was 35.9 percent. China supplied $267,445.02 thousand. Dividing the China value by the world total and rounding to one decimal, the calculated China share was 9.1 percent. A China stop removes that slice. The United States keeps shipping.
Mexico supplied $233,528.03 thousand. The calculated Mexico share was 7.9 percent. Germany supplied $217,916.02 thousand. The calculated Germany share was 7.4 percent. Japan supplied $147,619.87 thousand. The calculated Japan share was 5.0 percent. Mexico, Germany, and Japan keep shipping. Costa Rica supplied $124,076.28 thousand and Ireland supplied $100,578.06 thousand, and they keep shipping too.
Members cannot replace the import book at home. On the component-sourcing question, respondents saw no Australian component source at 84 percent. The survey collected 31 member companies and the response rate was approximately 30 percent. MTAA lists 85 industry members. That is the association, not a census of every sponsor.
The manufacturing exception is Cochlear. The 2024 tax contribution report says the group undertakes the majority of manufacturing and R&D in Australia, with three sites at Macquarie University, Lane Cove, and Brisbane, and contract manufacturing arrangements with subsidiaries in Sweden, Malaysia, and China. Approximately 95 percent of revenue was generated outside Australia. The China subsidiary is a distributor and a service provider for contract manufacturing.
Hospital buyers are the demand. There were 703 public hospitals. In 2024-25 there were 486,000 FTE staff working in public hospitals. That headcount is hospital staff, not device technicians. Public elective admissions reached 791,000, and half of patients were admitted within 45 days. Cataract surgery was 88,000 admissions. During 2023-24, hospital spending was $113.8 billion. That total is not a device bill.
The short-horizon cost analog is the MTAA air-freight chart, not an annual price index. In the last 6 months, air-freight costs were impacting supply chains for 81 percent of respondents. The air-freight chart printed a 10 percent increase. The inventory-holding step printed a 20 percent increase. A member comment records delays of 5-7 days receiving product.
Why an Australian device importer and a hospital buyer get hit
Step 1 is the China invoice. China supplied $267,445.02 thousand of HS 9018 in 2024. The calculated China share was 9.1 percent. The stop is that slice, not the world total of $2,945,335.84 thousand.
Step 2 is who keeps shipping. The calculated United States share was 35.9 percent. The calculated Mexico share was 7.9 percent. The calculated Germany share was 7.4 percent. The calculated Japan share was 5.0 percent. Costa Rica and Ireland remain named partners above $100,578.06 thousand.
Step 3 is the lane. Sea-freight costs were impacting 55 percent of respondents and air-freight costs were impacting 81 percent, both n=31, in the last 6 months. The footnote on the sea-freight chart says the majority of respondents solely use airfreight. The air-freight chart printed a 10 percent increase.
Step 4 is the component that is not a country share. Members report a shortage of printed circuit boards as an ongoing concern, and that competition for boards can slow medical-technology manufacturing. The AdvaMed page, which is not an Australian survey, prints delays from two to 52+ weeks and does not print a Taiwan share of chips inside a device.
Step 5 is the clinical counter. Half of public elective patients were admitted within 45 days. Cataract surgery, the clearest implant procedure on the release, was 88,000 admissions. There were 703 public hospitals. A device miss shows up as a wait, not as a closed Australian factory, except at the China contract site of the local implant maker.
How hard, how soon
1–6 months
The inventory-holding step printed a 20 percent increase. Raw-material costs were impacting 87 percent of respondents over the same last-6-months question. The next-6-months continuation question was 31 percent yes.
12+ months
The buyer budget analog is annual and small. Hospital spending was 1.2 percent higher than 2022-23. Public hospital spending rose 1.0 percent in real terms. These are not device prices. The long chip analog, from a non-Australian page, runs to 52+ weeks.
Wave 1
Air and sea gateways, with warehousing and truck drivers indirect because they depend on the gateway, fuel, and telecom.
Wave 2
Enterprise systems: device importers, Cochlear plants, and private-health-insurer platforms. Public and private hospital buyers, and the elective pathway, are indirect.
Wave 3
Outsourced logistics, small distributors, and small service firms. The all-business small-firm cost analog is $56,600.
Country exposure
origin sharepercent
the calculated United States share was 35.9 percent
WITSthe calculated China share was 9.1 percent
WITSThe calculated Mexico share was 7.9 percent
WITSThe calculated Germany share was 7.4 percent
WITSThe calculated Japan share was 5.0 percent
WITSCost and price shock by time bucket
Downstream scale
sitessites
There were 703 public hospitals
AIHWworkforcepeople
there were 486,000 FTE staff
AIHWchina invoicethousand USD
China supplied $267,445.02 thousand.
WITSOperating prints
daysdays
admitted within 45 days
AIHWFor repayment, providers will have 30 days to return the funds.
UnitedHealth Groupratespercent
saw no Australian component source at 84 percent
MTAAApproximately 95 percent of revenue was generated outside Australia.
Cochlearhospital spendbillion AUD
Hospital spending was $113.8 billion
AIHWWhat to do
Day 7
Tag open orders that are China-origin HS 9018. The baseline is China supplied $267,445.02 thousand. Keep the United States, Mexico, Germany, and Japan releases moving.
Ask the forwarder for the air-freight quote against the last contract. The air-freight chart printed a 10 percent increase inside a last-6-months survey.
Day 30
For the local implant maker, confirm which steps sit in China contract manufacturing and which sit at Macquarie, Lane Cove, and Brisbane. The China unit share was not printed. The majority of manufacturing is in Australia.
Hospital buyers list cataract and other implant procedures against the printed waits. Half of elective patients were admitted within 45 days. Cataract admissions were 88,000.
Day 90
Decide whether any component can move onshore. Respondents saw no Australian component source at 84 percent, so the default is another overseas partner, not a domestic plant.
Put a manual claim path next to the insurer and the hospital materials system. Cybersecurity protocols for supply-chain systems were in place for 87 percent of respondents, which is a baseline, not a proof the wave misses them.
What to watch
China-origin HS 9018 import value. Act when the annual China value falls by more than 50 percent from $267,445.02 thousand. Fifty percent is a planning line, not a WITS rule. The page does not publish a monthly series, so the weekly KPI is receipts against that annual baseline.
Public elective median wait. Act when the median wait exceeds 45 days. Half of patients were admitted within 45 days. Exceeding that print is a planning line set against the published baseline.
Air-freight quote versus the prior contract. Act when the quote is more than 10 percent above the prior contract. The air-freight chart printed a 10 percent increase. Using that step as a ceiling is a planning line.
Overseas share of ANZ-serving suppliers. Act when a supplier's overseas share is above 90 percent. The chart prints a 90-99 percent bucket and a 100 percent bucket. The 100 percent bucket was the answer for 44 percent of n=27 respondents. The tripwire is a planning line set against those printed buckets.
Share of implant-maker revenue collected outside Australia. Act when collections from outside Australia fall below 95 percent. Approximately 95 percent of revenue was generated outside Australia. The line is a planning line set against that printed baseline, not a Cochlear covenant.
By role
Device importer
Split the order book at the China invoice of $267,445.02 thousand.
Keep releases from the United States, Mexico, Germany, and Japan.
Re-quote air freight against the 10 percent step.
Domestic implant manufacturer
Map the China contract step separately from Macquarie, Lane Cove, and Brisbane.
Stress export collections against approximately 95 percent of revenue outside Australia.
Keep the Malaysia repair centre in the service plan.
Public hospital buyer
Track elective median wait against 45 days and cataract volume against 88,000 admissions.
Do not treat the $113.8 billion hospital total as a device budget.
Insurer and outsourced logistics
Write a manual payment path for implant claims funded inside the $10.5 billion private-insurance hospital spend.
Treat outsourced warehouses, 66 percent of respondents, as Wave 3 firms with their own access paths.
Weekly checks
China-origin HS 9018 receipts versus the 2024 invoice China supplied $267,445.02 thousand. A drop of more than half of that annual baseline is the planning tripwire. WITS did not print a monthly series.
Air-freight quote versus the prior contract The air-freight chart printed a 10 percent increase. A quote more than 10 percent above the prior contract is the planning line.
Public elective median wait, days Half of patients were admitted within 45 days. A median that exceeds 45 days is the clinical tripwire.
Share of ANZ-serving suppliers located overseas The printed 100 percent bucket was selected by 44 percent of n=27 respondents. Crossing above 90 percent is the concentration tripwire set against that chart.
Export collections for the domestic implant maker Approximately 95 percent of revenue was generated outside Australia. A print below 95 percent is a planning line set against that baseline, not a company covenant.
What is not known
Decision-changing limits. HS 9018 is not the U.S. HS 9018-9022 basket. Taiwan is not a named partner on the opened Australian table. That absence is the low-exposure proof. No page prints Taiwan's share of chips inside an Australian device, and that unpublished chip share is the cap. No days of device inventory, no device-only share of the $113.8 billion hospital total, no named-port device share, and no Cochlear China unit share were printed. Private-hospital staffing stops at 2016-17. No monthly Australian device price index was opened. The short operational print remains delays of 5-7 days. Tripwires at more than 50 percent, above 90 percent overseas, more than 10 percent on air freight, a wait that exceeds 45 days, and collections below 95 percent are planning lines.
wits.worldbank.orgadvamed.orgaihw.gov.auassets.cochlear.comaihw.gov.au
Calculated shares use the printed partner value and the printed world total of $2,945,335.84 thousand, then round to one decimal. The calculated United States share was 35.9 percent. The calculated China share was 9.1 percent. The calculated Mexico share was 7.9 percent. The calculated Germany share was 7.4 percent. The calculated Japan share was 5.0 percent. They are not printed percents on the WITS page.
Cyber wave order is a planning model. ACSC costs by size are all-business self-reports. Health care and social assistance at 6 percent of incidents is not a device-factory attack rate. A public hospital buyer is Wave 2 indirect. Cochlear's plants are Wave 2 direct. The air and sea gateway is Wave 1 direct.
Pharmaceuticals are out of scope. Hospital operations are in scope only as the customer for devices. The 486,000 FTE figure is public-hospital staff. The 194,659 nurse caption is not mixed into the 202,000 nurse bullet.
Working papers: node summary
| Node | Primary impact | Time horizon | Cyber wave | Evidence |
|---|---|---|---|---|
| Australian device importers | The China slice of instrument imports stops, and the United States, Mexico, Germany, and Japan keep shipping. | 0-6 months | Wave 2 (direct) | wits.worldbank.org |
| Air and sea freight gateways | Air-freight cost and delay hit the lane most surveyed members use to move devices. | 0-3 months | Wave 1 (direct) | mtaa.org.au |
| Warehousing staff and truck drivers | Inland handling stalls when the gateway or the fuel and telecom systems fail. | 0-3 months | Wave 1 (indirect) | mtaa.org.au |
| Public hospital buyers | Elective lists and device availability move across the public hospital network. | 0-12 months | Wave 2 (indirect) | aihw.gov.au |
| Private hospital buyers | Private-hospital accounts are the other device counter, and the bill is not device-only. | 0-12 months | Wave 2 (indirect) | aihw.gov.au |
| Cochlear Australian plants | Australian implant plants keep running, and the China contract-manufacturing arrangement stops. | 0-12 months | Wave 2 (direct) | cochlear.com |
| Cataract and elective-surgery pathway | Lens and other implant procedures wait longer when the device or the list system is late. | 0-12 months | Wave 2 (indirect) | aihw.gov.au |
| Outsourced logistics and small distributors | Outsourced warehouses and small distributors are the broad target after the enterprise importers. | 1-12 months | Wave 3 (direct) | mtaa.org.au |
| Small service and repair firms | Small service firms feel PCB and lead-time stress, and no Australian technician census was opened. | 1-12 months | Wave 3 (direct) | mtaa.org.au |
| Private health insurers paying hospital accounts | An insurer-platform outage can stop payment for an implant that has already been used. | 0-12 months | Wave 2 (direct) | aihw.gov.au |
Sources
- WITS Comtrade, Australia HS 9018 imports, 2024
- MTAA Supply Chain Survey 2024
- Cochlear Tax Contribution Report 2024
- AIHW public hospitals and beds, 2024-25
- AIHW hospital workforce
- AIHW health expenditure, hospitals, 2023-24
- AIHW elective surgery media release, 10 December 2025
- ACSC Annual Cyber Threat Report 2024-25, business factsheet
- CISA Volt Typhoon alert, 7 February 2024
- AdvaMed semiconductor shortage statement, 25 January 2022
- GAO-25-107755, healthcare cybersecurity
- UnitedHealth Group update on the Change Healthcare cyberattack, 7 March 2024